Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

NCT02201953

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Sacramento, California, United States
  • San Diego, California, United States
View all 76 locations
View Trial Details
Completed

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

NCT02073656

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
Locations
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • Newport Beach, California, United States
  • Palo Alto, California, United States
View all 41 locations
View Trial Details
Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

NCT02413593

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Calgary, Alberta, Canada
  • Edmonton, Alberta, Canada
  • Edmonton, Alberta, Canada
  • Vancouver, British Columbia, Canada
View all 15 locations
View Trial Details
Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

NCT01768286

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +17 more
Locations
  • Phoenix, Arizona, United States
  • Tucson, Arizona, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 53 locations
View Trial Details
Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection

NCT02480712

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • San Diego, California, United States
  • San Francisco, California, United States
View all 15 locations
View Trial Details

Related conditions